Pulmonx (LUNG) Free Cash Flow (2019 - 2025)
Pulmonx (LUNG) posted quarterly Free Cash Flow of -$8.2 million for Q3 2025, down 8.23% year-over-year from -$9.0 million in Q3 2024, and down 111.65% quarter-over-quarter from -$3.9 million in Q2 2025.
Pulmonx (LUNG) Free Cash Flow (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Free Cash Flow for 7 consecutive years, with -$8.2 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Free Cash Flow fell 8.23% year-over-year to -$8.2 million; the TTM figure through Dec 2025 stood at -$25.7 million (up 21.97% YoY), while the FY2024 annual figure was -$33.0 million, up 14.14% from the prior year.
- Free Cash Flow eased to -$8.2 million in Q3 2025 per LUNG's latest filing, from -$3.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$3.9 million in Q2 2025 and bottomed at -$15.6 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$9.9 million across 5 years, with a median of -$9.9 million in 2021.
- Annual changes were most pronounced in 2021 — Free Cash Flow sank 72.67% — and 2025, when it surged 37.82%.
- Pulmonx's Free Cash Flow stood at -$11.8 million in 2021, then climbed by 15.8% to -$10.0 million in 2022, then grew by 13.69% to -$8.6 million in 2023, then gained by 20.55% to -$6.8 million in 2024, then slipped by 20.6% to -$8.2 million in 2025.
- Business Quant data shows LUNG's Free Cash Flow at -$8.2 million in Q3 2025, -$3.9 million in Q2 2025, and -$13.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.25 Mn |
| Sep 30, 2025 | -8.25 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Mar 31, 2025 | -13.59 Mn |
| Mar 31, 2025 | -13.59 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Sep 30, 2024 | -7.62 Mn |
| Sep 30, 2024 | -7.62 Mn |
| Jun 30, 2024 | -6.27 Mn |
| Jun 30, 2024 | -6.27 Mn |
| Mar 31, 2024 | -12.25 Mn |
| Mar 31, 2024 | -12.25 Mn |
| Dec 31, 2023 | -8.61 Mn |
| Dec 31, 2023 | -8.61 Mn |
| Sep 30, 2023 | -8.82 Mn |
| Sep 30, 2023 | -8.82 Mn |
| Jun 30, 2023 | -7.87 Mn |
| Jun 30, 2023 | -7.87 Mn |